Gold will soon regain its lustre
Despite roaring commodity prices and central bankers stoking inflation, gold is being left behind. But that won't last.
“Everything’s glittering except for gold”, writes Mike Bird in The Wall Street Journal. You’d think these would be good times for gold. Commodities are roaring and central bankers seem keen to stoke inflation. Yet the yellow metal is being left behind. Trading at around $1,810/oz (£1,280/oz) this week gold is still more than 10% short of its early August highs. Even silver has been attracting more interest of late thanks to Reddit traders.
The idea that the surge in bitcoin, dubbed “digital gold” by some, is overshadowing the real thing has become a market commonplace, says Joe Weisenthal on Bloomberg. But it isn’t true. Bitcoin is really a “risk-on” asset that is more comparable with a stock like Tesla. Gold, by contrast, is a traditional safe haven strongly influenced by real interest rates (ie, interest rates adjusted for inflation). The metal’s main drawback as an asset is that it pays no interest, so when real interest rates rise – as they have done so far this year – investors tend to sell gold to buy up other assets.
Gold has had a “sour” start to the year, says Myra Saefong in Barron’s. Yet the longer term outlook remains encouraging. The current market rally rests on the unsteady base of “government stimulus and money printing”, says Peter Grosskopf of investment manager Sprott. Soaring US debt levels and a more inflationary outlook could yet prove a “tailwind” for gold.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
UK-US trade deal announced: US cuts tariffs on UK car imports to 10%
Keir Starmer and Donald Trump have announced a UK-US trade deal, but the US president has refused to lift baseline tariffs on most UK goods. What does it mean for the UK?
-
How to use mid-caps to diversify from the US
Medium sized companies are overlooked by investors but could offer an attractive ‘sweet spot’. We consider the case for mid-caps amid market volatility.
-
Will Comstock crash – or soar?
Opinion The upside for Comstock, a solar panel-recycling and biomass-refining group, dwarfs the downside, says Dominic Frisby.
-
'As AGMs go digital, firms must offer a new form of scrutiny for shareholders'
Opinion Technology has rendered big AGM meet-ups obsolete, but the board still needs to be held to account, says Matthew Lynn
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?
Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
-
Two ways to tap into monopoly profits from airports
Most investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?
The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategy
Ramsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance market
The insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocks
Opinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton